Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 30478-88-7 | MDL No. : | MFCD10000951 |
Formula : | C10H7BrO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PQVIOPAWVAOHOA-UHFFFAOYSA-N |
M.W : | 223.07 | Pubchem ID : | 45943 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 53.67 |
TPSA : | 20.23 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.32 cm/s |
Log Po/w (iLOGP) : | 2.18 |
Log Po/w (XLOGP3) : | 3.29 |
Log Po/w (WLOGP) : | 3.31 |
Log Po/w (MLOGP) : | 3.24 |
Log Po/w (SILICOS-IT) : | 3.16 |
Consensus Log Po/w : | 3.04 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.91 |
Solubility : | 0.0273 mg/ml ; 0.000122 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.39 |
Solubility : | 0.0909 mg/ml ; 0.000407 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.36 |
Solubility : | 0.0098 mg/ml ; 0.000044 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.18 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | General procedure: To a Schlenk flask were added 2-bromo-3-methoxynaphthalene(1.0 equiv), aryl boronic acid (2.2 equiv), K2CO3 (3.0 equiv), Pd(PPh3)4 (2.5 mol%), and degassedEtOH/toluene/water (1/1/1) under Ar atmosphere. The mixture was heated at 90 C until thecompletion of the reaction. Then the mixture was cooled to room temperature, and DCM was added.The mixture was washed with NaOH solution (20% wt), and the aqueous phase was extracted withDCM (2 × 20 mL). The combined organic phase was washed with brine (20 mL) and dried overanhydrous MgSO4. After removing the solvent, the residue was dissolved in anhydrous DCM. Thesolution was cooled to -78 C, and BBr3 (1 M in DCM, 5.0 equiv) was added slowly by syringe. Thenthe mixture was warmed up to room temperature and stirred until the complete consumption of thestarting material. The mixture was poured into the ice water (50 mL) and extracted with DCM (3 × 50mL). The combined organic phase was washed with brine (100 mL) and dried over anhydrous Na2SO4. After removing the solvent, the residue was purified by silica gel chromatography to givethe desired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With ferrous perchlorate; (1R,2R)?N1,N2?di(quinolin?8?yl)cyclohexane?1,2?diamine; oxygen; In chlorobenzene; at 50℃; under 760.051 Torr;Schlenk technique; Molecular sieve; | General procedure: (S)-[1,1?-Binaphthalene]-2,2?-diol (2a) [47]: Fe(ClO4)2 (12.7 mg, 10 mol%; NOTE: perchlorate salt isa potential explosive [72] and should be handled with extreme caution) and L1 (9.2 mg, 5 mol%) weredissolved in anhydrous PhCl (5 mL) in a 25 mL Schlenk tube, and the mixture was stirred at roomtemperature for 30 min. Then, 2-naphthol (72.3 mg, 0.5 mmol, 1.0 equiv) and MS 4A (152.7 mg) wereadded. The reaction mixture was quickly evacuated and refilled with oxygen (1 atm), and thisoperation was repeated for three cycles. Then the mixture was stirred at 50 C under oxygen, asmonitored by TLC. The desired product was obtained (60.6 mg, 84% yield) as a pale yellow solid afterpurification by silica gel chromatography (PE to PE/EA = 10/1 to 5/1). 80:20 er (HPLC: Chiralpak ASH,hexane/propan-2-ol = 90/10, 0.5 mL/min, lambda = 230 nm, tR (min): major = 24.9, minor = 38.9). 1H-NMR(400 MHz, Chloroform-d) delta 7.99 (d, J = 8.9 Hz, 2H), 7.90 (d, J = 7.9 Hz, 2H), 7.38 (td, J = 7.7, 1.6 Hz, 4H),7.31 (ddd, J = 8.2, 6.9, 1.4 Hz, 2H), 7.19-7.12 (m, 2H), 5.04 (s, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; water; toluene; at 95℃; for 2h; | Put in 7 mL of toluene, 3 mL of ethanol, and 3 mL of 20% by weight aqueous sodium carbonate solution were 0.73 g (1.5 mmol) of E7 and 0.40 g (1.8 mmol) of E8. Then, 0.21 g (0.18 mmol) of tetrakis ( triphenylphosphine ) palladium ( 0 ) was added, and the solution was heated to 95 degrees Celsius and was stirred for two hours. After cooling, water and toluene were added, the product was extracted with toluene, and the extract was dried with sodium sulfate. After the solvent was removed, the residue was purified by silica gel column chromatography (mobile phase: chloroform and heptane in a ratio of 1:7), thus yielding 0.35 g of E9 (yield: 46%). |
[ 1227743-83-0 ]
3,7-Dibromo-2,6-dihydroxynaphthalene
Similarity: 1.00
[ 132178-78-0 ]
1,5-Dibromonaphthalene-2,6-diol
Similarity: 0.96
[ 102153-56-0 ]
1,8-Dibromonaphthalene-2,7-diol
Similarity: 0.93
[ 1227743-83-0 ]
3,7-Dibromo-2,6-dihydroxynaphthalene
Similarity: 1.00
[ 132178-78-0 ]
1,5-Dibromonaphthalene-2,6-diol
Similarity: 0.96
[ 102153-56-0 ]
1,8-Dibromonaphthalene-2,7-diol
Similarity: 0.93